Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?
Status:
Unknown status
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
Aspirin (ASA) has been shown, in an animal model, to attenuate the ototoxic properties of
cisplatin. The researchers plan to investigate this in patients undergoing cisplatin
chemotherapy.
The researchers hypothesise that low-dose aspirin can prevent cisplatin induced ototoxicity
in the clinical setting.